JP2010526051A5 - - Google Patents

Download PDF

Info

Publication number
JP2010526051A5
JP2010526051A5 JP2010504894A JP2010504894A JP2010526051A5 JP 2010526051 A5 JP2010526051 A5 JP 2010526051A5 JP 2010504894 A JP2010504894 A JP 2010504894A JP 2010504894 A JP2010504894 A JP 2010504894A JP 2010526051 A5 JP2010526051 A5 JP 2010526051A5
Authority
JP
Japan
Prior art keywords
pyrazin
carboxamide
phenyl
amino
trifluoromethoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2010504894A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010526051A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2008/001062 external-priority patent/WO2008135830A1/en
Publication of JP2010526051A publication Critical patent/JP2010526051A/ja
Publication of JP2010526051A5 publication Critical patent/JP2010526051A5/ja
Withdrawn legal-status Critical Current

Links

JP2010504894A 2007-05-03 2008-04-21 疼痛を治療するためのnav1.8チャネルモジュレーターとしてのn−[6−アミノ−5−(フェニル)ピラジン−2−イル]−イソオキサゾール−4−カルボキサミド誘導体および関連化合物 Withdrawn JP2010526051A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US91575207P 2007-05-03 2007-05-03
US95753207P 2007-08-23 2007-08-23
PCT/IB2008/001062 WO2008135830A1 (en) 2007-05-03 2008-04-21 N- [6-amino-s- (phenyl) pyrazin-2-yl] -isoxazole-4-carboxamide derivatives and related compounds as nav1.8 channel modulators for the treatment of pain

Publications (2)

Publication Number Publication Date
JP2010526051A JP2010526051A (ja) 2010-07-29
JP2010526051A5 true JP2010526051A5 (enExample) 2011-06-02

Family

ID=39739527

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010504894A Withdrawn JP2010526051A (ja) 2007-05-03 2008-04-21 疼痛を治療するためのnav1.8チャネルモジュレーターとしてのn−[6−アミノ−5−(フェニル)ピラジン−2−イル]−イソオキサゾール−4−カルボキサミド誘導体および関連化合物

Country Status (5)

Country Link
US (1) US20100227872A1 (enExample)
EP (1) EP2155727A1 (enExample)
JP (1) JP2010526051A (enExample)
CA (1) CA2685952C (enExample)
WO (1) WO2008135830A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100007956A (ko) 2007-05-03 2010-01-22 화이자 리미티드 나트륨 채널 조절제로서의 2-피리딘 카복스아마이드 유도체
US9079878B2 (en) * 2011-10-26 2015-07-14 Pfizer Limited (4-phenylimidazol-2-yl) ethylamine derivatives useful as sodium channel modulators
WO2013114250A1 (en) 2012-02-03 2013-08-08 Pfizer Inc. Benziimidazole and imidazopyridine derivatives as sodium channel modulators
CN115703719B (zh) * 2021-08-03 2024-04-30 联化科技股份有限公司 一种溴化肟类化合物的制备方法
CA3256486A1 (en) 2022-04-25 2023-11-02 Siteone Therapeutics Inc Bicyclic Na V1.8 Heterocyclic Amide Inhibitors for Pain Management
WO2025160286A1 (en) 2024-01-24 2025-07-31 Siteone Therapeutics, Inc. 2-aryl cycloalkyl and heterocycloalkyl inhibitors of nav1.8 for the treatment of pain

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA26473A1 (fr) * 1997-03-01 2004-12-20 Glaxo Group Ltd Composes pharmacologiquement actifs.
EP1802580A2 (en) * 2004-07-23 2007-07-04 Pfizer, Inc. Pyridine derivatives
NL2000284C2 (nl) * 2005-11-04 2007-09-28 Pfizer Ltd Pyrazine-derivaten.

Similar Documents

Publication Publication Date Title
RU2455288C2 (ru) Соединения и композиции 5-(4-(галогеналкокси)фенил)пиримидин-2-амина в качестве ингибиторов киназ
RU2439068C2 (ru) Модуляторы mglur5
JP2009533410A5 (enExample)
RU2012132692A (ru) Новые ингибиторы s-нитрозоглутатионредуктазы
JP2010526051A5 (enExample)
JP2004504301A5 (enExample)
JP2011519854A5 (enExample)
JP2014530900A5 (enExample)
JP2012507566A5 (enExample)
JP2009542717A5 (enExample)
JP2008546791A5 (enExample)
JP2016503786A5 (enExample)
JP2007504160A5 (enExample)
RU2013104270A (ru) Производные урацила или тимина для лечения гепатита с
JP2008513516A5 (enExample)
JP2011504497A5 (enExample)
JP2014502979A5 (enExample)
JP2011521911A5 (enExample)
JP2018535235A5 (enExample)
JPWO2023195529A5 (enExample)
NZ596820A (en) Trans-4-[[(5s)-5-[[[3,5-bis(trifluoromethyl)phenyl]methyl] (2-methyl-2h-tetrazol-5-yl)amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1h-1-benzazepin-1-yl]methyl]-cyclohexanecarboxylic acid
JP2013544854A5 (enExample)
JP2010506919A5 (enExample)
JP2009531363A5 (enExample)
JP2006516626A5 (enExample)